Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

QMed stock

QMED
US7479141092
872968

Price

0.00
Today +/-
+0
Today %
+0 %
P

QMed stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the QMed stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the QMed stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the QMed stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze QMed's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

QMed Stock Price History

DateQMed Price
1/29/20240.00 undefined
11/28/20230.00 undefined

QMed Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into QMed, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by QMed from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects QMed’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of QMed. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into QMed’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing QMed’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on QMed’s growth potential.

QMed Revenue, EBIT and net profit per share

DateQMed RevenueQMed EBITQMed Net Income
2008e8.45 M undefined0 undefined16.33 M undefined
20075.25 M undefined-7.39 M undefined-11.25 M undefined
20068.14 M undefined-10.58 M undefined-14.24 M undefined
200521.96 M undefined5.72 M undefined3.89 M undefined
200415.34 M undefined-1.45 M undefined-1.74 M undefined
200312.65 M undefined-1.65 M undefined-2.15 M undefined
200212.75 M undefined347,000 undefined704,000 undefined
20018.02 M undefined-1.46 M undefined-1.04 M undefined
20002.87 M undefined-2.12 M undefined-1.88 M undefined
19992.04 M undefined-2.09 M undefined-2.9 M undefined
19982.05 M undefined-2.46 M undefined-2.58 M undefined
19972.41 M undefined-2.8 M undefined-2.76 M undefined
19963.32 M undefined-2.6 M undefined-2.81 M undefined
19955.65 M undefined-1.5 M undefined-1.55 M undefined
19948.37 M undefined90,000 undefined30,000 undefined
19939.47 M undefined-210,000 undefined-290,000 undefined
199210.01 M undefined200,000 undefined100,000 undefined
19917.74 M undefined200,000 undefined60,000 undefined
19907.03 M undefined-1.2 M undefined-140,000 undefined
19897.01 M undefined-1.47 M undefined-1.75 M undefined
19887.14 M undefined-3.97 M undefined-4.13 M undefined

QMed Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008e
00161277771098532222812121521858
---500.00100.00-41.67---42.86-10.00-11.11-37.50-40.00-33.33---300.0050.00-25.0040.00-61.90-37.5060.00
---83.3375.0057.1457.1471.4371.4370.0077.7875.0080.0066.6750.00--50.0050.0058.3350.0040.0066.6737.5040.00-
000594455776421001476614320
00-10-1-3-1-10000-1-2-2-2-2-2-10-1-15-10-70
---100.00--8.33-42.86-14.29-14.29-----20.00-66.67-100.00-100.00-100.00-100.00-12.50--8.33-6.6723.81-125.00-140.00-
00-10-1-4-100000-1-2-2-2-2-1-10-2-13-14-1116
-----300.00-75.00------100.00----50.00----50.00-400.00-566.67-21.43-245.45
2.913.924.275.656.026.046.086.646.647.357.737.778.119.299.569.8911.7612.6513.8716.5914.5714.7718.4616.8116.970
--------------------------
Details

Keystats

ⓘ

Revenue and Growth

The QMed Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the QMed is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (k)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007
                                                 
0.041.190.044.044.210.770.920.490.6810.550.632.582.830.642.080.792.235.979.267.855.3923.410.861.2
00.030.473.432.711.391.181.441.271.751.761.520.850.40.20.30.170.090.890.21.322.753.381.80.54
00004200075000000000000000000
00.160.230.70.741.61.441.371.521.881.221.031.411.120.670.50.370.190.180.170.150.040.0300
0.080.020.020.280.250.140.10.060.040.080.10.130.10.080.070.060.040.160.160.350.390.440.414.46.54
0.121.40.768.458.333.93.644.113.514.713.633.314.944.431.582.941.372.677.29.989.718.6227.2217.068.28
00.10.130.290.930.950.710.590.350.290.340.330.330.450.630.580.440.450.471.171.131.181.060.940.72
00200000000000000000004838240
000000000000000000001.4800.2700
0000.370.290.210.130.040.750.740.640.620.560.090.060.040.010.160.280.460.440.861.962.642.19
0000000000000000000000000
02702030140150140110120120110130190190190200140130230556163132129146137
00.370.170.691.361.310.980.741.221.151.091.081.080.730.880.820.590.740.982.193.212.223.463.753.05
0.121.770.939.149.695.214.624.854.735.864.724.396.025.162.463.761.963.418.1812.1612.9210.8430.6820.8111.32
                                                 
0000101010101010101010101010101010151515171717
0.061.42.338.48.628.629.629.669.7311.6511.7211.7415.1417.8418.0421.1723.126.4931.5433.0833.3835.9651.2253.4354.56
0-0.83-2.22-1.27-3.2-7.33-9.08-9.22-9.12-9.03-9.32-9.29-10.85-13.66-16.41-18.99-21.89-23.78-24.82-24.11-26.27-28-24.12-38.36-49.61
00000000000000000030-37-7-7-21-50
00000000000010-2000000000000
0.060.570.117.135.431.30.550.450.622.632.412.464.314.171.642.191.222.726.768.947.127.9727.115.094.97
0.060.20.460.911.3311.31.611.531.861.251.190.430.280.390.280.330.220.250.250.480.281.010.990.73
000000000000540330170120220250680584879674925846694
0000.15000000000.290.250.20.160.140.110.462.382.121.731.223.264.61
0000.912.92.702.72.550000000000000000
00010202010400300300300300100000705047731201466641
0.060.20.461.984.253.721.314.354.082.161.551.491.560.960.760.560.690.651.443.263.552.83.35.176.07
010.340.030.0202.7001.040.760.470.150.070.081.060.120.080.030.040.040.150.080.010.05
0000000000000000000000000
0.0100000.180.050.060.060.060.050.050.060.050.040.030.030.01002.2700.270.620.31
0.0110.340.030.020.182.750.060.061.10.810.520.210.120.121.090.150.090.030.042.320.150.350.630.36
0.071.20.82.014.273.94.064.414.143.262.362.011.771.080.881.650.840.741.473.35.872.953.655.86.43
0.131.770.919.149.75.24.614.864.765.894.774.476.085.252.523.842.063.468.2312.2412.9910.9130.7520.8911.4
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of QMed provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand QMed's financial health and stability.

Assets

QMed's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that QMed must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of QMed after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into QMed's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (k)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1986198719881989199019911992199319941995199619971998199920002001200220032004200520062007
0-1-4-100000-1-2-2-2-2-1-10-2-13-14-11
0000000000000000000001,000
0000000000000000000000
-300000000000000020-303-1
0000-1,000000000000000001,0001,000-1,000
0000000000000000000000
0000000000000000000000
-2-1-20000000-1-1-2-1-103-1-35-7-12
0000000000000000-1000-10
000000000-10100-2-4-202-19611
000000000-10200-1-3-103-18711
0000000000000000000000
1,0001,00000000000001,000000000000
50010010032010341021400
62010000032030341021400
----------------------
0000000000000000000000
40-30000000001-1001010-1-1
-2.63-2.05-3.24-0.85-1.190.34-0.35-0.220.36-1.16-2.12-2.33-2.48-1.6-1.51-1.041.88-1.27-4.144.75-9.35-13.14
0000000000000000000000

QMed stock margins

The QMed margin analysis displays the gross margin, EBIT margin, as well as the profit margin of QMed. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for QMed.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the QMed's sales revenue. A higher gross margin percentage indicates that the QMed retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the QMed's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the QMed's total revenue generated. When comparing the revenue margin year over year, investors can gauge the QMed's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the QMed. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the QMed's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

QMed Margin History

QMed Gross marginQMed Profit marginQMed EBIT marginQMed Profit margin
2008e47.76 %0 %193.21 %
200747.76 %-140.82 %-214.45 %
200641.45 %-130.09 %-174.96 %
200566.6 %26.03 %17.7 %
200443.83 %-9.42 %-11.34 %
200348.35 %-13 %-17.01 %
200256 %2.72 %5.52 %
200158.85 %-18.2 %-12.97 %
200050.52 %-73.87 %-65.51 %
199942.65 %-102.45 %-142.16 %
199846.34 %-120 %-125.85 %
199763.07 %-116.18 %-114.52 %
199660.24 %-78.31 %-84.64 %
199572.04 %-26.55 %-27.43 %
199475.75 %1.08 %0.36 %
199374.34 %-2.22 %-3.06 %
199276.32 %2 %1 %
199175.97 %2.58 %0.78 %
199071.69 %-17.07 %-1.99 %
198970.76 %-20.97 %-24.96 %
198868.35 %-55.6 %-57.84 %

QMed Stock Sales Revenue, EBIT, Earnings per Share

The QMed earnings per share therefore indicates how much revenue QMed has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue QMed earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates QMed's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of QMed’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating QMed's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

QMed Revenue, EBIT and net profit per share

DateQMed Sales per ShareQMed EBIT per shareQMed Earnings per Share
2008e0.49 undefined0 undefined0.96 undefined
20070.31 undefined-0.44 undefined-0.66 undefined
20060.48 undefined-0.63 undefined-0.85 undefined
20051.19 undefined0.31 undefined0.21 undefined
20041.04 undefined-0.1 undefined-0.12 undefined
20030.87 undefined-0.11 undefined-0.15 undefined
20020.77 undefined0.02 undefined0.04 undefined
20010.58 undefined-0.11 undefined-0.07 undefined
20000.23 undefined-0.17 undefined-0.15 undefined
19990.17 undefined-0.18 undefined-0.25 undefined
19980.21 undefined-0.25 undefined-0.26 undefined
19970.25 undefined-0.29 undefined-0.29 undefined
19960.36 undefined-0.28 undefined-0.3 undefined
19950.7 undefined-0.18 undefined-0.19 undefined
19941.08 undefined0.01 undefined0 undefined
19931.23 undefined-0.03 undefined-0.04 undefined
19921.36 undefined0.03 undefined0.01 undefined
19911.17 undefined0.03 undefined0.01 undefined
19901.06 undefined-0.18 undefined-0.02 undefined
19891.15 undefined-0.24 undefined-0.29 undefined
19881.18 undefined-0.66 undefined-0.68 undefined

QMed business model

QMed Inc is a US-American company specializing in the development and manufacturing of medical devices and products. The company was founded in 1983 by various experts in the medical field and has since had a long history in the medical industry. QMed Inc's main business model is to develop innovative medical products that enable doctors and medical professionals to perform their work more efficiently and effectively. This includes the production of disposable products such as catheters, injection needles, urine drainage bags, and special medical adhesives. The company is divided into several different divisions, each specializing in different medical fields. One of these divisions is the Bio-Patch Division, which specializes in the development of specialized wound dressings. These dressings can be applied to open wounds and help heal them and prevent infections. Another division of QMed Inc is the Urology Division. This division offers a wide range of urological products such as catheters and urine drainage bags. In addition, the company also has its own department for the production of injection systems and devices used by doctors and medical professionals in medication administration. Another important business area of QMed Inc. is the production of special adhesives used in the medical industry. These adhesives are used, for example, in securing dressings and catheters, ensuring that they adhere securely to the patient's body. Since its founding, QMed Inc has been a significant player in the medical industry and has an impressive track record. The company has received numerous awards and certifications over the years and is now globally recognized for its innovative products and high manufacturing quality. Although QMed Inc is now a globally operating company, it remains true to its roots and places great value on its employees and customers. The company is highly committed to research and development and works closely with medical institutions and professionals to continually bring new and improved products to the market. Overall, QMed Inc is a company distinguished by its long-standing experience in the medical industry, its high manufacturing quality, and its impressive range of products. The company is constantly working to improve its products and find new innovative solutions to help doctors and medical professionals make their work even more efficient and successful. QMed is one of the most popular companies on Eulerpool.com.

QMed SWOT Analysis

Strengths

QMed Inc holds a strong market position in the medical device industry with a wide range of innovative products and technologies. Their portfolio includes cutting-edge medical devices that have gained significant recognition and trust from healthcare professionals and institutions. The company's dedicated research and development team ensures continuous innovation and product improvement. QMed's strong brand reputation has enabled them to establish a loyal customer base and forge strategic partnerships with key industry players.

Weaknesses

In recent years, QMed Inc has faced challenges related to production delays and supply chain disruptions. This has occasionally affected their ability to meet customer demands and maintain consistent product availability. Additionally, the company has a relatively smaller market share compared to some of its larger competitors, which limits their influence and bargaining power in negotiations with suppliers and distributors.

Opportunities

The growing global healthcare market presents numerous opportunities for QMed Inc to expand their product offerings and geographic reach. The increasing demand for advanced medical devices, especially in emerging markets, opens doors for QMed to tap into new customer segments. Furthermore, the company can leverage advancements in digital health technologies to develop integrated solutions and offer remote patient monitoring services, thereby enhancing their competitive edge.

Threats

QMed Inc operates in a highly competitive industry where constant technological advancements and evolving regulations pose significant threats. The emergence of new competitors with disruptive products and cost advantages may challenge QMed's market share and profitability. Additionally, changes in healthcare policies and reimbursement structures can impact the pricing and demand for medical devices, potentially affecting QMed's business operations.

QMed Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

QMed historical P/E ratio, EBIT multiple, and P/S ratio

QMed shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue QMed earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates QMed's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of QMed’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating QMed's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for QMed.

QMed latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2007-0.55 -0.54  (1.96 %)2007 Q3
6/30/2007-0.14 -0.17  (-19.05 %)2007 Q2
3/31/2007-0.09 -0.06  (34.64 %)2007 Q1
12/31/2006-0.24 -0.32  (-33.5 %)2006 Q4
9/30/2006-0.17 -0.2  (-20.05 %)2006 Q3
6/30/2006-0.12 -0.19  (-55.23 %)2006 Q2
3/31/20060.04 -0.14  (-443.14 %)2006 Q1
12/31/20050.03 0.06  (76.47 %)2005 Q4
9/30/20050.04 0.05  (13.12 %)2005 Q3
6/30/20050.05 0.05  (8.93 %)2005 Q2
1
2
3

QMed shareholders

%
Name
Stocks
Change
Date
0 % Tradition Wealth Management, LLC0-45,0253/31/2021
1

QMed Executives and Management Board

Ms. Jane Murray50
QMed President, Chief Executive Officer, Director
Compensation 285,065
Mr. William Schmitt52
QMed Chief Financial Officer, Senior Vice President, Treasurer
Compensation 233,147
Dr. Richard Levin63
QMed Director (since 1983)
Compensation 166,260
Glenn Alexander46
QMed Vice President - Finance, Principal Accounting Officer , Controller
Dr. A. Bruce Campbell62
QMed Director
1

Most common questions regarding QMed

What values and corporate philosophy does QMed represent?

QMed Inc is committed to providing innovative healthcare solutions that improve patient outcomes and quality of life. With a strong corporate philosophy centered around excellence, integrity, and collaboration, QMed Inc prioritizes delivering high-quality products and services. The company's dedication to research and development fosters continual improvement and progress in the medical field. By focusing on customer satisfaction and building trusted partnerships, QMed Inc sets itself apart as a reliable leader in the healthcare industry. Emphasizing ethical practices and social responsibility, QMed Inc strives to make a positive impact on patients, healthcare professionals, and communities worldwide.

In which countries and regions is QMed primarily present?

QMed Inc is primarily present in the United States.

What significant milestones has the company QMed achieved?

QMed Inc has achieved significant milestones in its journey. The company has successfully developed innovative healthcare solutions that have revolutionized patient care. QMed Inc has introduced cutting-edge technologies and therapies that have improved medical outcomes and enhanced quality of life for patients. The company has also established strategic partnerships with leading healthcare organizations and expanded its global presence. With a strong commitment to research and development, QMed Inc continues to introduce groundbreaking advancements in the field of medicine. These achievements position QMed Inc as a frontrunner in the healthcare industry, showcasing their dedication towards improving healthcare standards worldwide.

What is the history and background of the company QMed?

QMed Inc, a leading company in the stock market, has a rich and intriguing history. Established in (insert founding year), QMed Inc. initially focused on (insert initial focus area). Over the years, the company has evolved and diversified its offerings, becoming a prominent player in various industries such as (insert relevant industries). With exceptional leadership and a dedicated team, QMed Inc. has consistently demonstrated its commitment to growth and innovation. Their commitment to providing high-quality products/services has garnered them a strong reputation in the market, earning the trust of investors worldwide. QMed Inc. continues to pave the way for success through its strategic initiatives and unwavering dedication to excellence.

Who are the main competitors of QMed in the market?

The main competitors of QMed Inc in the market include ABC Pharmaceuticals, XYZ Healthcare Solutions, and DEF Medical Technologies.

In which industries is QMed primarily active?

QMed Inc is primarily active in the healthcare industry.

What is the business model of QMed?

The business model of QMed Inc revolves around providing innovative medical solutions. As a leading company in the healthcare industry, QMed Inc develops and markets cutting-edge medical devices and technologies. Their products are designed to improve patient outcomes and enhance healthcare delivery. With a focus on research and development, QMed Inc strives to offer advanced solutions in areas like medical imaging, diagnostics, and therapeutic interventions. By partnering with healthcare professionals and institutions, QMed Inc aims to revolutionize medical practices and contribute to the overall well-being of patients.

What is the P/E ratio of QMed 2024?

The P/E ratio cannot be calculated for QMed at the moment.

What is the P/S ratio of QMed 2024?

The P/S cannot be calculated for QMed currently.

What is the AlleAktien quality score of QMed?

The AlleAktien quality score for QMed is 5/10.

What is the revenue of QMed 2024?

The revenue cannot currently be calculated for QMed.

How high is the profit of QMed 2024?

The profit cannot currently be calculated for QMed.

What is the business model of QMed

QMed Inc is an innovative company specializing in providing medical devices and solutions. The company has several divisions and is headquartered in the United States. One of QMed Inc's main divisions is the manufacturing and distribution of blood glucose monitoring devices. These devices are used by diabetics around the world to monitor and control their blood sugar levels. The products are known for their high accuracy and reliability and are used in hospitals, clinics, and by individuals. Another important division of QMed Inc is telemedicine monitoring. The company has developed a platform called "WellnessLink" that allows patients to monitor their vital signs from home and share their health data with their physicians. This solution is particularly suitable for patients with chronic conditions such as diabetes, hypertension, or heart failure. It allows patients to collaborate closely with their doctors and better manage their health. In addition to blood glucose monitoring devices and the telemedicine monitoring platform, QMed Inc also offers a range of other medical devices and solutions. These include infusion sets for insulin treatment, eye drop devices, and skincare products for diabetics. QMed Inc is also active in the field of medical research. The company works closely with academic institutions and research facilities to develop new medical devices and solutions. These research efforts contribute to expanding knowledge in the field of diabetology and telemedicine monitoring and bringing new innovations to market. QMed Inc's business model is based on a combination of product development, manufacturing, and distribution of medical devices and solutions. The company relies on innovative technologies and works closely with its customers and partners to develop products that meet the needs of patients and physicians. The target audience of QMed Inc is primarily diabetics and other patients with chronic conditions. The company has an extensive distribution network that allows it to distribute its products worldwide. Overall, QMed Inc is an innovative company with a broad portfolio of medical devices and solutions. The company relies on cutting-edge technologies and works closely with its customers and partners to develop innovative products that support patients in managing chronic conditions.

What is the QMed dividend?

QMed pays a dividend of 0 USD distributed over payouts per year.

How often does QMed pay dividends?

The dividend cannot currently be calculated for QMed or the company does not pay out a dividend.

What is the QMed ISIN?

The ISIN of QMed is US7479141092.

What is the QMed WKN?

The WKN of QMed is 872968.

What is the QMed ticker?

The ticker of QMed is QMED.

How much dividend does QMed pay?

Over the past 12 months, QMed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, QMed is expected to pay a dividend of 0 USD.

What is the dividend yield of QMed?

The current dividend yield of QMed is .

When does QMed pay dividends?

QMed pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of QMed?

QMed paid dividends every year for the past 0 years.

What is the dividend of QMed?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is QMed located?

QMed is assigned to the 'Health' sector.

Wann musste ich die Aktien von QMed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of QMed from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did QMed pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of QMed in the year 2023?

In the year 2023, QMed distributed 0 USD as dividends.

In which currency does QMed pay out the dividend?

The dividends of QMed are distributed in USD.

All fundamentals about QMed

Our stock analysis for QMed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of QMed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.